{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:48:14Z","timestamp":1776912494737,"version":"3.51.2"},"reference-count":20,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1111\/jcpt.12375","type":"journal-article","created":{"date-parts":[[2016,3,6]],"date-time":"2016-03-06T07:40:30Z","timestamp":1457250030000},"page":"260-265","source":"Crossref","is-referenced-by-count":46,"title":["Midodrine for the weaning of vasopressor infusions"],"prefix":"10.1155","volume":"41","author":[{"given":"L. B.","family":"Poveromo","sequence":"first","affiliation":[{"name":"Department of Pharmacy; Wake Forest Baptist Medical Center; Winston-Salem NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. L.","family":"Michalets","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Mission Health System; Eshelman School of Pharmacy; University of North Carolina; Asheville NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. E.","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Greenville Health System Care Coordination Institute; Greenville SC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2016,3,4]]},"reference":[{"key":"10.1111\/jcpt.12375-BIB0001|jcpt12375-cit-0001","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1111\/jcpt.12375-BIB0002|jcpt12375-cit-0002","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","article-title":"Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease","volume":"118","author":"Overgaard","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jcpt.12375-BIB0003|jcpt12375-cit-0003","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1476-5381.2011.01588.x","article-title":"Use of inotropes and vasopressor agents in critically ill patients","volume":"165","author":"Bangash","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jcpt.12375-BIB0004|jcpt12375-cit-0004","volume-title":"Midodrine hydrochloride tablet package insert","year":"2012"},{"key":"10.1111\/jcpt.12375-BIB0005|jcpt12375-cit-0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"key":"10.1111\/jcpt.12375-BIB0006|jcpt12375-cit-0006","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1986.101","article-title":"Pharmacodynamics of midodrine, an antihypotensive agent","volume":"39","author":"Zachariah","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12375-BIB0007|jcpt12375-cit-0007","first-page":"447","article-title":"The bioavailability of midodrin and alpha-2,5-dimethoxyphenyl-beta-aminoethanol hydrochloride","volume":"37","author":"Grobecker","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"10.1111\/jcpt.12375-BIB0008|jcpt12375-cit-0008","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","article-title":"Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group","volume":"277","author":"Low","year":"1997","journal-title":"JAMA"},{"key":"10.1111\/jcpt.12375-BIB0009|jcpt12375-cit-0009","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2011.04.027","article-title":"Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study","volume":"56","author":"Singh","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/jcpt.12375-BIB0010|jcpt12375-cit-0010","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1111\/jcpt.12375-BIB0011|jcpt12375-cit-0011","first-page":"101","article-title":"Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up","volume":"50","author":"Cruz","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1111\/jcpt.12375-BIB0012|jcpt12375-cit-0012","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1253\/circj.CJ-10-0514","article-title":"Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome","volume":"75","author":"Chen","year":"2011","journal-title":"Circ J"},{"key":"10.1111\/jcpt.12375-BIB0013|jcpt12375-cit-0013","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/europace\/eur200","article-title":"Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial)","volume":"13","author":"Romme","year":"2011","journal-title":"Europace"},{"key":"10.1111\/jcpt.12375-BIB0014|jcpt12375-cit-0014","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00003643-200211000-00015","article-title":"Midodrine, an alternative to intravenous vasopressor therapy after spinal surgery","volume":"19","author":"O'Donnell","year":"2002","journal-title":"Eur J Anaesthesiol"},{"key":"10.1111\/jcpt.12375-BIB0015|jcpt12375-cit-0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/107424840501000109","article-title":"Successful treatment of hypotension associated with stunned myocardium with oral midodrine therapy","volume":"10","author":"Sharma","year":"2005","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1111\/jcpt.12375-BIB0016|jcpt12375-cit-0016","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/1074248408317709","article-title":"Oral midodrine is effective for the treatment of hypotension associated with carotid artery stenting","volume":"13","author":"Sharma","year":"2008","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1111\/jcpt.12375-BIB0017|jcpt12375-cit-0017","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jcrc.2013.05.021","article-title":"Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions","volume":"28","author":"Levine","year":"2013","journal-title":"J Crit Care"},{"key":"10.1111\/jcpt.12375-BIB0018|jcpt12375-cit-0018","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12375-BIB0019|jcpt12375-cit-0019","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12375-BIB0020|jcpt12375-cit-0020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12375","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12375\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:01:20Z","timestamp":1671818480000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,4]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12375","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,4]]}}}